CR MEDICAL Holdings Limited entered into a framework agreement for Travel Services with CR Digital Technology on December 30, 2024, effective from January 1, 2025, to December 31, 2027. According to the agreement, CR Digital Technology Group will provide CR MEDICAL Group with business travel services including air tickets, Lodging, train tickets, and car-hailing services.The pricing is based on a cost-plus principle, and service fees will be fairly determined by both parties, referencing market rates. The transaction limit for each year from 2025 to 2027 is set at 20 million yuan. Since the applicable percentage rate exceeds 0.1% but is below 5%, the transaction must comply with the declaration, announcement, and annual audit requirements under Chapter 14A of the Listing Rules, but is exempt from compliance with circular and...Show More

CR MEDICAL Holdings Limited entered into a framework agreement for Travel Services with CR Digital Technology on December 30, 2024, effective from January 1, 2025, to December 31, 2027. According to the agreement, CR Digital Technology Group will provide CR MEDICAL Group with business travel services including air tickets, Lodging, train tickets, and car-hailing services.The pricing is based on a cost-plus principle, and service fees will be fairly determined by both parties, referencing market rates. The transaction limit for each year from 2025 to 2027 is set at 20 million yuan. Since the applicable percentage rate exceeds 0.1% but is below 5%, the transaction must comply with the declaration, announcement, and annual audit requirements under Chapter 14A of the Listing Rules, but is exempt from compliance with circular and independent Shareholder approval requirements.CR MEDICAL stated that this agreement allows for the consolidation of employee booking needs, leveraging CR Digital Technology's platform to obtain more competitive prices, while simplifying the booking process and reducing management costs. The company has implemented internal control measures to monitor related transactions, ensuring alignment with the overall interests of the company and its Shareholders.